The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...
The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...
Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...
Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC) and standalone influenza vaccines. The FDA lifted a clinical hold that ...
Leveraging the work and relationships already existing from our Phase II study, we have global clinical trial sites that are prepared and excited to participate in our Phase II program. Additionally, ...
Elsewhere, a Phase III trial in the US has been planned for BioVie’s Triolex (bezisterim), which is an inhibitor of ...
Between 2008 and 2011, Prof Toh’s team conceptualised and led a phase II single-arm clinical trial with 35 patients with ...
Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...
EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...
“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza.” ...
The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback